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Background: Minimally invasive surgery has been slowly introduced into the field of advanced gastric cancer (AGC)
surgery. However, the appropriate extent of omentectomy during laparoscopic gastrectomy for AGC is unknown.
Methods: From July 2004 to December 2011, 146 patients with serosa-negative advanced gastric cancer were
divided into the total omentectomy group (TO group, n = 80) and the partial omentectomy group (PO group,
n = 66). The clinicopathologic characteristics, surgical outcomes, recurrence pattern and survival were analyzed.
Results: There were no significant differences in the clinicopathologic features between the two groups, except for
depth of invasion; more T3 (subserosal invasion) cases (65%) were included in total omentectomy group (P = 0.011).
The mean time for PO was significantly shorter (35.1 ± 13.0 min) than TO (50.9 ± 15.3 min) (P <0.001), and there
were two omentectomy-related complications in the TO group: spleen and mesocolon injuries. Recurrence occurred
in 14 (17.5%) and 5 (7.6%) cases in the TO and PO group, respectively (P = 0.054). Disease-free survival (TO versus
PO: 81.5% versus 89.3%, P = 0.420) and disease-specific survival (TO versus PO: 89% versus 94.7%) were not
significantly different between the two groups. In the case-matched analysis using propensity score matching, there
was no difference in disease-free survival (TO versus PO: 83.3% versus 90.5%, P = 0.442).
Conclusions: Partial omentectomy might be an oncologically safe procedure during laparoscopic gastrectomy for
serosa-negative advanced gastric cancer, similar to early gastric cancer.
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Laparoscopic gastrectomy for advanced gastric cancer
(AGC) is not widely used, but interest in the procedure
is increasing [1-3]. Therefore, in Korea, the KLASS-02
trial (NCT01456598) began in 2012 to compare laparo-
scopic and open subtotal gastrectomy in local AGC. In
the surgical procedure for AGC, D2 dissection with total
omentectomy is mandatory for both laparoscopic gastrec-
tomy and open gastrectomy. Although D2 dissection has
an oncologic benefit in AGC, the role of total omentect-
omy is still questionable, particularly for serosa-negative
AGC [4,5]. In fact, dissection through the avascular plane
with proper countertraction of the transverse colon can* Correspondence: kimwook@catholic.ac.kr
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unless otherwise stated.lead to rapid and satisfactory total omentectomy during
open surgery; however, in laparoscopic gastrectomy, total
omentectomy is time-consuming and poses a risk of injury
to the adjacent organs, particularly the spleen and colon.
According to the Japanese gastric cancer treatment guide-
lines, partial omentectomy may be performed in cases
of T1 and T2, and total omentectomy is the standard
procedure for T3 or deeper tumors [6]. The main pur-
pose of performing total omentectomy is to remove all
of the potential seeding lesions in the event of serosal
exposure of the tumor cells (T4a). The aim of this study
was to elucidate the feasibility of partial omentectomy,
based on surgical and oncologic aspects, compared with
total omentectomy during laparoscopic gastrectomy for
serosa-negative AGC.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Kim et al. World Journal of Surgical Oncology 2014, 12:64 Page 2 of 6
http://www.wjso.com/content/12/1/64Methods
Patients and variables
The data of 530 patients who had undergone laparo-
scopic gastrectomy from July 2004 to December 2011
were retrospectively reviewed. Among these patients,
146 with histologically confirmed serosa-negative AGC
were evaluated. The patients were divided into a total
omentectomy group (TO group, n = 80) and a partial
omentectomy group (PO group, n = 66) based on the
surgical procedure that they had undergone. The type of
omentectomy was determined according to intraopera-
tive gross findings regarding the status of serosal expos-
ure. Total omentectomy was performed in cases of
suspected serosal tumor infiltration, and partial omen-
tectomy was performed in definitively serosa-negative
cases. The omentectomy time was defined as the time
from the initial division of the omentum to the comple-
tion of both sides of the gastroepiploic vessels. Clinico-
pathologic features; postoperative surgical outcomes,
including the omentectomy time; disease-specific and
disease-free survival; and the pattern of recurrence were
compared between the two groups. To compensate for
the selection bias, a case-matched analysis using propen-
sity score matching was additionally performed based on
T-stage and N-stage. This study was approved by institu-
tional review board in Catholic Medical Center, Korea.
Surgical procedure
All of the patients were placed in a supine position and
subjected to a 15 to 20° reverse Trendelenburg position.
First, routine exploration of the abdominal cavity and
tumor lesion was performed to exclude peritoneal metas-
tasis and definite serosal invasion.
Total omentectomy was performed via the same proced-
ure as in open gastrectomy. The assistant grasped the
transverse colon with an atraumatic grasper to ensure a se-
cure dissection plane, and division of the greater omentum
along the avascular plane using ultrasonic shear (Ethicon
Endo-Surgery, Cincinnati, OH, USA) was started from the
middle part of the transverse colon and extended up to
the lower pole of the spleen. The left gastroepiploic vessels
were divided to remove lymph node number 4sb. The
right side of the omentum was divided along the trans-
verse colon and the hepatic flexure. The dissection was
continued toward the inferior border of the pancreas head
and neck area, and the right gastroepiploic vessels were
exposed and divided at their origin with removal of lymph
node number 6. In cases of partial omentectomy, the div-
ision was started from the greater omentum at the line 4
to 5 cm from the gastroepiploic arcade using an ultrasonic
shear toward the origin of the left gastroepiploic vessels.
The omental branch was typically identified and preserved
to prevent a possible omental infarct. The procedures for
the right side were same as for total omentectomy.Statistical analysis
Clinicopathologic features and surgical outcomes were
analyzed using an unpaired t-test for continuous vari-
ables and the chi-square test or Fisher’s exact test for
nominal variables. In the univariate survival analysis, the
Kaplan-Meier and log-rank tests were used. All statis-
tical analyses were performed using SPSS 17.0 (SPSS
Inc., Chicago, IL, USA). A P value of <0.05 was considered
to be statistically significant.
Results
Clinicopathologic features and surgical outcomes
There were no significant differences between the groups,
including regarding lymph node status and TNM staging,
except for the depth of invasion. More T3 cases (65%)
underwent total omentectomy, and more T2 cases (56.1%)
underwent partial omentectomy (P = 0.011; Table 1). The
two groups did not significantly differ regarding other
clinicopathologic findings, including sex, age, the type of
resection, tumor size, histologic type, resected margins,
and the number of retrieved and metastatic lymph nodes.
In the surgical results, the mean time for partial omen-
tectomy was significantly shorter (35.1 ± 13.0 min) than
that for total omentectomy (50.9 ± 15.3 min) (P <0.001).
There were two omentectomy-related complications in
the TO group, including spleen and mesocolon injuries,
requiring concurrent splenectomy and transverse colec-
tomy (Table 2).
Recurrence and survival
During the follow-up period, a total of 19 recurrences
were identified, including 14 (17.3%) in the TO group and
5 (7.6%) in the PO group. Among the T2 cases, 2 recur-
rences occurred in the 3rd-tier lymph node and bone in
the TO group, and 2 recurrences occurred in the bone,
with simultaneous 3rd-tier lymph node metastasis and
remnant stomach cancer in the PO group. Among the T3
cases, there were 13 recurrences in the TO group: 3 carci-
nomatoses, 3 distant lymph node metastases, 3 remnant
stomach tumors, and 4 cases of hematogenous spread (3
in the liver and 1 in the bone). Three recurrence cases, in-
cluding 1 carcinomatosis, 1 liver site, and 1 port site, oc-
curred in the PO group among T3 cases (Table 3).
There were no significant differences in cumulative
disease-free survival (TO versus PO: 81.5% versus 89.3%,
P = 0.420) or disease-specific survival (TO versus PO:
89.0% versus 94.7%, P = 0.624) between the two groups
(Figure 1). In addition, there was no difference in the de-
velopment of recurrence in the omentum or of carcin-
omatosis (TO versus PO: 3/80 (3.8%) versus 1/66 (1.5%),
P = 0.410) (Table 3). To overcome the selection bias due
to the T-stage discrepancy between the two groups, Cox
Table 1 The clinicopathologic features of patients with serosa-negative advanced gastric cancer (AGC) according to the
type of omentectomy
Variable Total omentectomy (n = 80) Partial omentectomy (n = 66) P
Age (years)a 60.9 ± 11.2 62.2 ± 11.0 0.483
Sex Male 56 (70) 50 (75.8) 0.438
Female 24 (30) 16 (24.2)
Extent of resection Total 19 (23.8) 12 (18.2) 0.413
Distal 61 (76.3) 54 (81.8)
Depth of invasion pT2 28 (35) 37 (56.1) 0.011
pT3 52 (65) 29 (43.9)
Lymph node metastasis 0 40 (50) 34 (51.5) 0.419
1 14 (17.5) 8 (12.1)
2 13 (16.3) 16 (24.2)
3a 6 (7.5) 6 (9.1)
3b 7 (8.8) 2 (3.0)
Tumor stage (UICC 7th) Ib 17 (21.3) 23 (34.8) 0.130
IIa 30 (37.5) 15 (22.7)
IIb 9 (11.3) 11 (16.7)
IIIa 13 (16.3) 12 (18.2)
IIIb 11 (13.8) 5 (7.6)
Tumor size (cm)a 4.8 ± 2.5 4.4 ± 2.4 0.366
Histologic type Differentiated 37 (46.3) 24 (36.4) 0.228
Undifferentiated 43 (53.8) 42 (63.6)
Proximal margin (cm)a 4.0 ± 2.1 3.7 ± 2.2 0.357
Distal margin (cm)a 5.3 ± 3.4 6.4 ± 4.2 0.083
Lymphatic invasion Absent 27 (33.8) 30 (45.5) 0.149
Present 53 (66.3) 36 (54.5)
Perineural invasion Absent 39 (48.8) 40 (60.6) 0.152
Present 42 (51.3) 26 (39.4)
aMean ± standard deviation; nominal variables are expressed as number (%).
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the following covariates: the type of omentectomy, tumor
depth, and lymph node status (Table 4). This analysis
revealed that the type of omentectomy was not a risk
factor for recurrence.Table 2 Surgical outcomes in patients with serosa-negative a
omentectomy
Variable Total omente
Lymph node (LN) dissection D1 + β 2 (2.5)
D2 78 (97.5)
Number of retrieved LNsa 34.6 ± 14.7
Number of metastatic LNsa 4.3 ± 8.5
Omentectomy time (min)a 50.9 ± 15.5
Omentectomy-related complication 2b
Recurrence 14 (17.5)
aMean ± standard deviation; nominal variables are expressed as number (%).
bComplications included intra-operative spleen and mesocolon injury, requiring conCase-matched analysis
Propensity score matching yielded 51 patients in each
group. Table 5 shows the same proportions of T-stage
and N-stage in the two matched groups. A comparison
of disease-free survival between the two matched groupsdvanced gastric cancer (AGC) according to the type of
ctomy (n = 80) Partial omentectomy (n = 66) P
6 (7.6) 0.153
61 (92.4)
39.8 ± 14.7 0.034
2.9 ± 5.3 0.228
35.1 ± 13.0 <0.001
0 0.198
5 (7.6) 0.076
current splenectomy and transverse colectomy.
Table 3 Recurrence pattern according to the type of































aProportion of carcinomatosis in total omentectomy versus partial
omentectomy: 3/80 (3.8%) versus 1/66 (1.5%), P = 0.410 (chi-square analysis).
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90.5%, P = 0.442) (Figure 1C).
Discussion
Laparoscopic gastrectomy for early gastric cancer (EGC)
has been widely performed, and its advantages over open
gastrectomy have been verified in many randomized
clinical trials [7-11]. Recently, laparoscopic gastrectomy
for AGC has been increasingly performed, and certain
reports have outlined its feasibility from technical and
oncologic perspectives [1-3]. In laparoscopic gastrec-
tomy for AGC, D2 dissection and total omentectomy
have been the primary troublesome issues for many lap-
aroscopic surgeons.
Although the greater omentum is known to play a role
in peritoneal defense by adhering to sites of inflammationFigure 1 Survival analysis. (A) Disease-free survival did not differ betwee
groups. (B) Disease-specific overall survival did not differ between the tota
survival did not differ between the matched groups.and absorbing bacteria and other contaminants, it is a
common site of both recurrent disease and primary seed-
ing in gastrointestinal malignancies [12]. Additionally, sev-
eral experimental studies have reported that cancer cells
seeded in the peritoneal cavity preferentially grow on the
omentum [12,13]. For this reason, total omentectomy has
been a standard operative procedure during open gastrec-
tomy, regardless of tumor depth. However, if there is no
serosal exposure, cancer cell spillage or spread through
the omentum is not theoretically possible. Therefore, we
hypothesized that partial omentectomy is sufficient for T2
and even T3 cases. The most important type of recurrence
relevant to omentectomy may be carcinomatosis. Kim
et al. and Ha et al. reported no survival difference be-
tween TO and PO in EGC [14,15]. Kim et al. [16] re-
ported no difference in the pattern of recurrence between
TO and PO in AGC without serosal exposure during open
gastrectomy. The researchers also detected no difference
in the rate of peritoneal metastasis among all recurrences
(35% and 25% in TO and PO, respectively). In our series,
although more recurrences were noted in the TO group
than in the PO group, there was no difference in survival
between the two groups. In addition, there was no differ-
ence in the occurrence of carcinomatosis between the two
groups. Interestingly, approximately half of the T3 cases
(25 cases) in the TO group were regarded as including
definite serosal invasion (T4a) intra-operatively but were
finally proven to encompass subserosal invasion (T3) his-
tologically. Despite the paucity of serosal exposure in the
pathologic findings, certain investigators believe that the
peritoneum can form a new surface over exposed cancer
cells in clinically T4a lesions. Koji et al. reported that the
width of subserosal invasion is an independent risk factor
for survival in histologically confirmed T3 gastric cancer
[17]. We believe that clinical serosal exposure in histologi-
cally confirmed T3 cases involves a larger width of subser-
osal invasion or even focal serosal penetration, which may
be why the number of recurrences was much higher in
the TO group.n the total omentectomy (TO) and the partial omentectomy (PO)
l omentectomy and the partial omentectomy groups. (C) Disease-free
Table 4 Univariate and multivariate analyses of the risk factors for recurrence
Variable Univariate Multivariate
5 yr DFSa (%) P Odds ratio P
Type of omentectomy Total 81.5 0.42 1 0.766
Partial 89.3 0.85 (0.30 to 2.43)
Depth of invasion pT2 92.5 0.015 1 0.082
pT3 77.5 3.00 (0.87 to 10.39)
Lymph node metastasis Absent 97.2 <0.001 1 0.003
Present 68.5 9.98 (2.06 to 39.14)
aDisease-free survival.
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we were unable to determine the exact reason because all
of the cases had negative margins for malignancy and be-
cause remnant gastric cancer lesions were not involved in
the anastomosis line. The Japanese gastric cancer treat-
ment guidelines (2010; version 3) recommend leaving a
proximal margin of at least 3 cm in the presence of an ex-
pansive growth pattern and of 5 cm in the presence of an
infiltrative growth pattern or evaluating frozen sections
when these factors cannot be observed [6]. Considering
that the interval between the initial operation and the
completion of gastrectomy was relatively short (1 year for
2 patients and 2 years for the others), there may have been
undetected cancer lesions in the remnant stomach, despite
preoperative gastrofiberscopy.
Moriguchi et al. [18] have reported that serosal invasion
and Borrmann type 4 carcinoma are independent risk fac-
tors for the development of carcinomatosis. Although no
randomized controlled trials have been performed, Fugita
et al. [19] also showed that the type of omentectomy was
not a risk factor for recurrence in serosa-negative AGC in
a retrospective study, and they included several serosal ex-
posure cases (T4a). The researchers also showed that the
development of carcinomatosis has no relationship with
the type of omentectomy. The most important factor for
justifying the selection of partial omentectomy is tumor
depth. The accuracy of preoperative evaluation by endo-









Depth of invasion pT2 22 (43.1) 22 (43.1) 1.000
pT3 29 (56.9) 29 (43.9)
Lymph node
metastasis
0 28 (54.9) 28 (54.9) 1.000
1 8 (15.7) 8 (15.7)
2 11 (21.6) 11 (21.6)
3a 2 (3.9) 2 (3.9)
3b 2 (3.9) 2 (3.9)and Kim et al. reported that the accuracy of macroscopic
findings in determining whether a tumor had invaded the
serosa was 87% [16]. Therefore, if we select the type of op-
eration conservatively, with consideration of preoperative
evaluations, we can avoid performing partial omentect-
omy in T4a cases.
In previous reports comparing total omentectomy and
partial omentectomy in EGC, partial omentectomy
showed several advantages over total omentectomy, in-
cluding in operation time, perioperative complications,
and the postoperative albumin level [14,15]. Total omen-
tectomy in open gastrectomy is no more difficult than
partial omentectomy. With traction of the transverse
colon by an assistant, the dissection of the greater omen-
tum can be easily performed through the avascular plane.
Otherwise, in laparoscopic gastrectomy, total omentect-
omy can be a more challenging procedure because main-
taining the dissection line through the avascular plane and
dividing the omental tissue from the mesocolon are not
easy, particularly in patients with a high BMI. In the
present study, PO demonstrated several advantages in
terms of surgical outcomes. The omentectomy time was
shorter, and omentectomy-related complications did not
occur in the PO group. However, omental infarction may
occur during PO and can appear as carcinomatosis or
omental recurrence in radiologic findings [3]. It is import-
ant to differentiate between various radiological findings
and omental infarcts [20], and close follow-up is required
when differentiation is difficult, particularly in the imme-
diate postoperative period.
Because the present study was retrospectively de-
signed, it has certain limitations. Although there was no
significant difference in the distribution of stages be-
tween the two groups, the TO group contained more ad-
vanced cases. These discrepancies in tumor staging may
influence the recurrence rate. However, omentectomy
was not risk factor for recurrence in the multivariate
analysis. Despite these limitations, the present study is
valuable because previous reports were based on open
gastrectomy, so this is the first report to evaluate the
role of the type of omentectomy in laparoscopic gastrec-
tomy for serosa-negative AGC.
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In conclusion, partial omentectomy can be a useful alter-
native method for performing laparoscopic gastrectomy
for serosa-negative AGC. However, to determine long-
term technical and oncologic safety, a prospective ran-
domized controlled trial is needed.
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